ArticleAnnals of medicine and surgery (2012)2025
Anti-inflammatory potential of royal jelly in multiple sclerosis disease: a double randomized clinical trial.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Royal jelly fermented byBiochemistry and biophysics reports · 2025Article
- The impacts of natural polyphenols and exercise alone or together on microRNAs and angiogenic signaling.Frontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multiple sclerosis (MS) is a chronic, autoimmune, and neurodegenerative disease that affects the central nervous system. Royal jelly (RJ), a nutrient-rich substance known for its anti-inflammatory and antioxidant properties, holds potential in impeding disease progression by mitigating inflammatory processes and oxidative stress. This study was undertaken to explore the impact of RJ on oxidative stress and inflammatory markers in individuals diagnosed with MS. Methods: This randomized clinical trial involved the allocation of 35 MS patients into two groups: intervention ( Results: After the intervention, the mean EDSS score significantly decreased in the case group compared to pre-intervention ( Conclusion: Our findings suggest that RJ supplementation may have beneficial effects on inflammatory markers, oxidative stress indices and quality of life in MS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.